NLRP3 and coronary atherosclerosis: In this study, we reported an abnormallyhigh level of serum NLRP3 in patients with coronary atherosclerosis, whichroughly matches with those seen in earlier investigations, reconfirming thepathogenic potential of NLRP3 in atherogenesis [13, 14].